Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

PHARMA

Quarterly rpt on consolidated results for the financial period ended 31/3/2006

PHARMANIAGA BERHAD

Quarterly report for the financial period ended

31/03/2006
Quarter1
Financial Year End31/12/2006
The figureshave not been audited

Attachments

Pharmaniaga_1st qtr_06031.doc
510 KB

SUMMARY OF KEY FINANCIAL INFORMATION
31/03/2006


INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR CORRESPONDING QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR CORRESPONDING PERIOD
31/03/2006 
31/03/2005 
31/03/2006 
31/03/2005 
 
 
 
 
RM'000
RM'000
RM'000
RM'000
1Revenue
250,754
227,872
250,754
227,872
2Profit/(loss) before tax
8,911
18,249
8,911
18,249
3Profit/(loss)
after tax and minority
interest
5,459
10,699
5,459
10,699
4Net profit/(loss) for
the period
5,459
10,699
5,459
10,699
5Basic earnings/(loss) per share (sen)
5.10
10.48
5.10
10.48
6Dividend per share (sen)
0.00
0.00
0.00
0.00



AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR
END
7Net assets per share (RM)

3.1300
2.9800

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my


Remarks :
No interim ordinary dividend has been declared for the financial period ended 31 March 2006 (2005: nil).


Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced25 May 2006  
CategoryFinancial Results
Reference NoPB-060525-35068